4//SEC Filing
Kalb Michael Wayne 4
Accession 0001161697-25-000026
CIK 0001369568other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:00 PM ET
Size
9.2 KB
Accession
0001161697-25-000026
Insider Transaction Report
Form 4
Kalb Michael Wayne
Executive Vice President & CFO
Transactions
- Tax Payment
Common Stock, par value $0.001 per share
2025-01-02−2,941→ 4,197 total - Exercise/Conversion
Common Stock, par value $0.001 per share
2025-01-02+7,138→ 7,138 total - Exercise/Conversion
Restricted Stock Units
2025-01-02−7,138→ 475,699 total→ Common Stock (7,138 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
- [F3]Derivative securities vest in equal tranches, 1/5th each on January 1, 2025, 2026, 2027, 2028 and 2029.
- [F4]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on January 2, 2025.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001678248
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:00 PM ET
- Size
- 9.2 KB